{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T13:04:08Z","timestamp":1794488648057,"version":"4.9.1"},"reference-count":106,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":29,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["P01 AI117915"],"award-info":[{"award-number":["P01 AI117915"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["P01 AI178377"],"award-info":[{"award-number":["P01 AI178377"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["P30 AI064518"],"award-info":[{"award-number":["P30 AI064518"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R03 AI142341"],"award-info":[{"award-number":["R03 AI142341"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R56 DK140173"],"award-info":[{"award-number":["R56 DK140173"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-76412-8","type":"journal-article","created":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T03:16:50Z","timestamp":1786591010000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Commensal bacteria inhibit viral infections via a tryptophan metabolite"],"prefix":"10.1038","volume":"17","author":[{"given":"Danting","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Soo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chin Yee","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sedem","family":"Dankwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsuan-Yuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara S.","family":"Theriot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2518-8567","authenticated-orcid":false,"given":"Keyi","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Demitrius","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4330-4659","authenticated-orcid":false,"given":"Amir","family":"Ardeshir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8917-9187","authenticated-orcid":false,"given":"James R.","family":"Bain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6150-1149","authenticated-orcid":false,"given":"Sarah M.","family":"Heston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5079-9920","authenticated-orcid":false,"given":"Jillian H.","family":"Hurst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4453-4488","authenticated-orcid":false,"given":"Nazema Y.","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7375-1337","authenticated-orcid":false,"given":"Koen K. A.","family":"Van Rompay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1662-7345","authenticated-orcid":false,"given":"Luisa","family":"Cervantes-Barragan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan P.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rinn","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8851-1352","authenticated-orcid":false,"given":"Jatin","family":"Roper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew S.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G.","family":"Hudgens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5199-3004","authenticated-orcid":false,"given":"Kristina","family":"De Paris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1438-4554","authenticated-orcid":false,"given":"Sallie R.","family":"Permar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4574-5431","authenticated-orcid":false,"given":"Ria","family":"Goswami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9544-2551","authenticated-orcid":false,"given":"Neeraj K.","family":"Surana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,13]]},"reference":[{"key":"76412_CR1","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1126\/science.abj7965","volume":"374","author":"J-L Casanova","year":"2021","unstructured":"Casanova, J.-L. & Abel, L. Mechanisms of viral inflammation and disease in humans. Science 374, 1080\u20131086 (2021).","journal-title":"Science"},{"key":"76412_CR2","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/s41579-021-00639-z","volume":"20","author":"RE Baker","year":"2022","unstructured":"Baker, R. E. et al. Infectious disease in an era of global change. Nat. Rev. Microbiol. 20, 193\u2013205 (2022).","journal-title":"Nat. Rev. Microbiol."},{"key":"76412_CR3","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1016\/j.cell.2020.08.021","volume":"182","author":"DM Morens","year":"2020","unstructured":"Morens, D. M. & Fauci, A. S. Emerging pandemic diseases: how we got to COVID-19. Cell 182, 1077\u20131092 (2020).","journal-title":"Cell"},{"key":"76412_CR4","doi-asserted-by":"publisher","first-page":"E7118","DOI":"10.1073\/pnas.1521644112","volume":"112","author":"J-L Casanova","year":"2015","unstructured":"Casanova, J.-L. Human genetic basis of interindividual variability in the course of infection. Proc. Natl. Acad. Sci. USA 112, E7118\u2013E7127 (2015).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"76412_CR5","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1056\/NEJMoa2008457","volume":"382","author":"MM Arons","year":"2020","unstructured":"Arons, M. M. et al. Presymptomatic SARS-CoV-2 infections and transmission in a skilled nursing facility. N. Engl. J. Med. 382, 2081\u20132090 (2020).","journal-title":"N. Engl. J. Med."},{"key":"76412_CR6","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1038\/ni1529","volume":"8","author":"HW Virgin","year":"2007","unstructured":"Virgin, H. W. In vivo veritas: pathogenesis of infection as it actually happens. Nat. Immunol. 8, 1143\u20131147 (2007).","journal-title":"Nat. Immunol."},{"key":"76412_CR7","doi-asserted-by":"crossref","unstructured":"Karim, M., Lo, C.-W. & Einav, S. Preparing for the next viral threat with broad-spectrum antivirals. J. Clin. Invest. 133, e170236 (2023).","DOI":"10.1172\/JCI170236"},{"key":"76412_CR8","doi-asserted-by":"publisher","DOI":"10.1126\/science.aad5872","volume":"351","author":"JK Pfeiffer","year":"2016","unstructured":"Pfeiffer, J. K. & Virgin, H. W. Transkingdom control of viral infection and immunity in the mammalian intestine. Science 351, aad5872 (2016).","journal-title":"Science"},{"key":"76412_CR9","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.4049\/jimmunol.2100215","volume":"207","author":"CY Tan","year":"2021","unstructured":"Tan, C. Y., Ramirez, Z. E. & Surana, N. K. A modern-world view of host-microbiota-pathogen interactions. J. Immunol. 207, 1710\u20131718 (2021).","journal-title":"J. Immunol."},{"key":"76412_CR10","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1146\/annurev-virology-111821-115754","volume":"10","author":"DE Campbell","year":"2023","unstructured":"Campbell, D. E., Li, Y., Ingle, H. & Baldridge, M. T. Impact of the microbiota on viral infections. Annu. Rev. Virol. 10, 371\u2013395 (2023).","journal-title":"Annu. Rev. Virol."},{"key":"76412_CR11","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1126\/science.1210718","volume":"334","author":"M Kane","year":"2011","unstructured":"Kane, M. et al. Successful transmission of a retrovirus depends on the commensal microbiota. Science 334, 245\u2013249 (2011).","journal-title":"Science"},{"key":"76412_CR12","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.chom.2013.12.004","volume":"15","author":"CM Robinson","year":"2014","unstructured":"Robinson, C. M., Jesudhasan, P. R. & Pfeiffer, J. K. Bacterial lipopolysaccharide binding enhances virion stability and promotes environmental fitness of an enteric virus. Cell Host Microbe 15, 36\u201346 (2014).","journal-title":"Cell Host Microbe"},{"key":"76412_CR13","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1126\/science.1211057","volume":"334","author":"SK Kuss","year":"2011","unstructured":"Kuss, S. K. et al. Intestinal microbiota promote enteric virus replication and systemic pathogenesis. Science 334, 249\u2013252 (2011).","journal-title":"Science"},{"key":"76412_CR14","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1126\/science.1104816","volume":"307","author":"F Backhed","year":"2005","unstructured":"Backhed, F., Ley, R. E., Sonnenburg, J. L., Peterson, D. A. & Gordon, J. I. Host-bacterial mutualism in the human intestine. Science 307, 1915\u20131920 (2005).","journal-title":"Science"},{"key":"76412_CR15","first-page":"4197","volume":"124","author":"NK Surana","year":"2014","unstructured":"Surana, N. K. & Kasper, D. L. Deciphering the tete-a-tete between the microbiota and the immune system. J. Clin. Invest. 124, 4197\u20134203 (2014).","journal-title":"J. Clin. Invest."},{"key":"76412_CR16","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1016\/j.cell.2020.10.047","volume":"183","author":"KL Stefan","year":"2020","unstructured":"Stefan, K. L., Kim, M. V., Iwasaki, A. & Kasper, D. L. Commensal microbiota modulation of natural resistance to virus infection. Cell 183, 1312\u20131324 (2020).","journal-title":"Cell"},{"key":"76412_CR17","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1126\/science.aam5336","volume":"357","author":"AL Steed","year":"2017","unstructured":"Steed, A. L. et al. The microbial metabolite desaminotyrosine protects from influenza through type I interferon. Science 357, 498\u2013502 (2017).","journal-title":"Science"},{"key":"76412_CR18","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1126\/science.1258025","volume":"347","author":"MT Baldridge","year":"2015","unstructured":"Baldridge, M. T. et al. Commensal microbes and interferon-lambda determine persistence of enteric murine norovirus infection. Science 347, 266\u2013269 (2015).","journal-title":"Science"},{"key":"76412_CR19","doi-asserted-by":"crossref","unstructured":"Van Winkle, J. A. et al. Homeostatic interferon-lambda response to bacterial microbiota stimulates preemptive antiviral defense within discrete pockets of intestinal epithelium. ELife11, e74072 (2022).","DOI":"10.7554\/eLife.74072"},{"key":"76412_CR20","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/j.tim.2022.01.007","volume":"30","author":"NI Wirusanti","year":"2022","unstructured":"Wirusanti, N. I., Baldridge, M. T. & Harris, V. C. Microbiota regulation of viral infections through interferon signaling. Trends Microbiol. 30, 778\u2013792 (2022).","journal-title":"Trends Microbiol."},{"key":"76412_CR21","doi-asserted-by":"publisher","DOI":"10.1128\/msphere.00839-21","volume":"7","author":"AD Curtis","year":"2022","unstructured":"Curtis, A. D. et al. Vaccine-induced, high-magnitude HIV Env-specific antibodies with Fc-mediated effector functions are insufficient to protect infant rhesus macaques against oral SHIV infection. mSphere 7, e0083921 (2022).","journal-title":"mSphere"},{"key":"76412_CR22","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/S2352-4642(19)30024-0","volume":"3","author":"AJ Prendergast","year":"2019","unstructured":"Prendergast, A. J. et al. Transmission of CMV, HTLV-1, and HIV through breastmilk. Lancet Child Adolesc. Health 3, 264\u2013273 (2019).","journal-title":"Lancet Child Adolesc. Health"},{"key":"76412_CR23","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1089\/aid.2017.0169","volume":"34","author":"AM Amedee","year":"2018","unstructured":"Amedee, A. M. et al. Early sites of virus replication after oral SIV(mac251) infection of infant macaques: implications for pathogenesis. AIDS Res. Hum. Retrovir. 34, 286\u2013299 (2018).","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"76412_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1283343","volume":"14","author":"D Jiang","year":"2023","unstructured":"Jiang, D. et al. Sutterella and its metabolic pathways positively correlate with vaccine-elicited antibody responses in infant rhesus macaques. Front. Immunol. 14, 1283343 (2023).","journal-title":"Front. Immunol."},{"key":"76412_CR25","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/nature25019","volume":"552","author":"NK Surana","year":"2017","unstructured":"Surana, N. K. & Kasper, D. L. Moving beyond microbiome-wide associations to causal microbe identification. Nature 552, 244\u2013247 (2017).","journal-title":"Nature"},{"key":"76412_CR26","doi-asserted-by":"publisher","first-page":"906","DOI":"10.3389\/fmicb.2017.00906","volume":"8","author":"RA Nahui Palomino","year":"2017","unstructured":"Nahui Palomino, R. A., Zicari, S., Vanpouille, C., Vitali, B. & Margolis, L. Vaginal lactobacillus inhibits HIV-1 replication in human tissues ex vivo. Front. Microbiol. 8, 906 (2017).","journal-title":"Front. Microbiol."},{"key":"76412_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13468-9","volume":"10","author":"RA Nahui Palomino","year":"2019","unstructured":"Nahui Palomino, R. A. et al. Extracellular vesicles from symbiotic vaginal lactobacilli inhibit HIV-1 infection of human tissues. Nat. Commun. 10, 5656 (2019).","journal-title":"Nat. Commun."},{"key":"76412_CR28","doi-asserted-by":"publisher","first-page":"e206069","DOI":"10.1001\/jamapediatrics.2020.6069","volume":"175","author":"R Song","year":"2021","unstructured":"Song, R. et al. Sensitive and feasible specimen collection and testing strategies for diagnosing tuberculosis in young children. JAMA Pediatr. 175, e206069\u2013e206069 (2021).","journal-title":"JAMA Pediatr."},{"key":"76412_CR29","doi-asserted-by":"publisher","first-page":"228","DOI":"10.4049\/immunohorizons.2200096","volume":"7","author":"ZE Ramirez","year":"2023","unstructured":"Ramirez, Z. E. & Surana, N. K. Ruminococcus gnavus and Limosilactobacillus reuteri Regulate Reg3gamma Expression through Multiple Pathways. Immunohorizons 7, 228\u2013234 (2023).","journal-title":"Immunohorizons"},{"key":"76412_CR30","doi-asserted-by":"publisher","first-page":"2855","DOI":"10.1128\/JVI.72.4.2855-2864.1998","volume":"72","author":"EJ Platt","year":"1998","unstructured":"Platt, E. J., Wehrly, K., Kuhmann, S. E., Chesebro, B. & Kabat, D. Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1. J. Virol. 72, 2855\u20132864 (1998).","journal-title":"J. Virol."},{"key":"76412_CR31","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1128\/AAC.46.6.1896-1905.2002","volume":"46","author":"X Wei","year":"2002","unstructured":"Wei, X. et al. Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy. Antimicrob. Agents Chemother. 46, 1896\u20131905 (2002).","journal-title":"Antimicrob. Agents Chemother."},{"key":"76412_CR32","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1038\/nprot.2011.330","volume":"6","author":"D Daelemans","year":"2011","unstructured":"Daelemans, D., Pauwels, R., De Clercq, E. & Pannecouque, C. A time-of-drug addition approach to target identification of antiviral compounds. Nat. Protoc. 6, 925\u2013933 (2011).","journal-title":"Nat. Protoc."},{"key":"76412_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-02667-3","volume":"7","author":"S Callegaro","year":"2017","unstructured":"Callegaro, S. et al. A core extended naphtalene diimide G-quadruplex ligand potently inhibits herpes simplex virus 1 replication. Sci. Rep. 7, 2341 (2017).","journal-title":"Sci. Rep."},{"key":"76412_CR34","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1093\/clinchem\/44.4.858","volume":"44","author":"M Huengsberg","year":"1998","unstructured":"Huengsberg, M. et al. Serum kynurenine-to-tryptophan ratio increases with progressive disease in HIV-infected patients. Clin. Chem. 44, 858\u2013862 (1998).","journal-title":"Clin. Chem."},{"key":"76412_CR35","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/S1473-3099(03)00773-4","volume":"3","author":"MF Murray","year":"2003","unstructured":"Murray, M. F. Tryptophan depletion and HIV infection: a metabolic link to pathogenesis. Lancet Infect. Dis. 3, 644\u2013652 (2003).","journal-title":"Lancet Infect. Dis."},{"key":"76412_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05470-4","volume":"9","author":"HM Roager","year":"2018","unstructured":"Roager, H. M. & Licht, T. R. Microbial tryptophan catabolites in health and disease. Nat. Commun. 9, 3294 (2018).","journal-title":"Nat. Commun."},{"key":"76412_CR37","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.mib.2017.05.006","volume":"38","author":"MC Waller","year":"2017","unstructured":"Waller, M. C., Bober, J. R., Nair, N. U. & Beisel, C. L. Toward a genetic tool development pipeline for host-associated bacteria. Curr. Opin. Microbiol. 38, 156\u2013164 (2017).","journal-title":"Curr. Opin. Microbiol."},{"key":"76412_CR38","doi-asserted-by":"publisher","first-page":"e00127","DOI":"10.1128\/jb.00127-23","volume":"205","author":"J Arnold","year":"2023","unstructured":"Arnold, J., Glazier, J. & Mimee, M. Genetic engineering of resident bacteria in the gut microbiome. J. Bacteriol. 205, e00127\u201300123 (2023).","journal-title":"J. Bacteriol."},{"key":"76412_CR39","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1126\/science.aah5825","volume":"357","author":"L Cervantes-Barragan","year":"2017","unstructured":"Cervantes-Barragan, L. et al. Lactobacillus reuteri induces gut intraepithelial CD4(+)CD8alphaalpha(+) T cells. Science 357, 806\u2013810 (2017).","journal-title":"Science"},{"key":"76412_CR40","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.immuni.2013.08.003","volume":"39","author":"T Zelante","year":"2013","unstructured":"Zelante, T. et al. Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22. Immunity 39, 372\u2013385 (2013).","journal-title":"Immunity"},{"key":"76412_CR41","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.38867","volume":"7","author":"T Kueck","year":"2018","unstructured":"Kueck, T., Cassella, E., Holler, J., Kim, B. & Bieniasz, P. D. The aryl hydrocarbon receptor and interferon gamma generate antiviral states via transcriptional repression. ELife 7, e38867 (2018).","journal-title":"ELife"},{"key":"76412_CR42","doi-asserted-by":"publisher","unstructured":"Fulcher, J. A. et al. Gut dysbiosis and inflammatory blood markers precede HIV with limited changes after early seroconversion. eBioMedicine84, https:\/\/doi.org\/10.1016\/j.ebiom.2022.104286 (2022).","DOI":"10.1016\/j.ebiom.2022.104286"},{"key":"76412_CR43","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s00281-013-0395-3","volume":"35","author":"BP Lawrence","year":"2013","unstructured":"Lawrence, B. P. & Vorderstrasse, B. A. New insights into the aryl hydrocarbon receptor as a modulator of host responses to infection. Semin. Immunopathol. 35, 615\u2013626 (2013).","journal-title":"Semin. Immunopathol."},{"key":"76412_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.624293","volume":"12","author":"MF Torti","year":"2021","unstructured":"Torti, M. F., Giovannoni, F., Quintana, F. J. & Garcia, C. C. The Aryl Hydrocarbon Receptor as a Modulator of Anti-viral Immunity. Front. Immunol. 12, 624293 (2021).","journal-title":"Front. Immunol."},{"key":"76412_CR45","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2024.2333748","volume":"16","author":"SM Heston","year":"2024","unstructured":"Heston, S. M. et al. The effects of antibiotic exposures on the gut resistome during hematopoietic cell transplantation in children. Gut Microbes 16, 2333748 (2024).","journal-title":"Gut Microbes"},{"key":"76412_CR46","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s40506-021-00253-w","volume":"13","author":"N Jakharia","year":"2021","unstructured":"Jakharia, N., Howard, D. & Riedel, D. J. CMV Infection in hematopoietic stem cell transplantation: prevention and treatment strategies. Curr. Treat. Options Infect. Dis. 13, 123\u2013140 (2021).","journal-title":"Curr. Treat. Options Infect. Dis."},{"key":"76412_CR47","doi-asserted-by":"publisher","first-page":"e2875","DOI":"10.1093\/cid\/ciaa1693","volume":"73","author":"JH Hurst","year":"2021","unstructured":"Hurst, J. H. et al. Severe acute respiratory syndrome coronavirus 2 infections among children in the biospecimens from respiratory virus-exposed kids (BRAVE Kids) study. Clin. Infect. Dis. 73, e2875\u2013e2882 (2021).","journal-title":"Clin. Infect. Dis."},{"key":"76412_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-023-01202-6","volume":"15","author":"LH Nguyen","year":"2023","unstructured":"Nguyen, L. H. et al. Metagenomic assessment of gut microbial communities and risk of severe COVID-19. Genome Med. 15, 49 (2023).","journal-title":"Genome Med."},{"key":"76412_CR49","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1136\/gutjnl-2020-323020","volume":"70","author":"YK Yeoh","year":"2021","unstructured":"Yeoh, Y. K. et al. Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19. Gut 70, 698\u2013706 (2021).","journal-title":"Gut"},{"key":"76412_CR50","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1093\/infdis\/jiaf325","volume":"232","author":"D Jiang","year":"2025","unstructured":"Jiang, D. et al. Decreased microbiota-driven tyrosine metabolism is associated with symptomatic COVID-19 in children. J. Infect. Dis. 232, 796\u2013805 (2025).","journal-title":"J. Infect. Dis."},{"key":"76412_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112020","volume":"42","author":"AM Ortiz","year":"2023","unstructured":"Ortiz, A. M. et al. Experimental bacterial dysbiosis with consequent immune alterations increase intrarectal SIV acquisition susceptibility. Cell Rep. 42, 112020 (2023).","journal-title":"Cell Rep."},{"key":"76412_CR52","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1038\/s41385-018-0029-0","volume":"11","author":"Y Sui","year":"2018","unstructured":"Sui, Y. et al. Influence of gut microbiome on mucosal immune activation and SHIV viral transmission in naive macaques. Mucosal Immunol. 11, 1219\u20131229 (2018).","journal-title":"Mucosal Immunol."},{"key":"76412_CR53","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1111\/cmi.12588","volume":"18","author":"B Williams","year":"2016","unstructured":"Williams, B., Landay, A. & Presti, R. M. Microbiome alterations in HIV infection a review. Cell Microbiol. 18, 645\u2013651 (2016).","journal-title":"Cell Microbiol."},{"key":"76412_CR54","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.cell.2018.07.038","volume":"174","author":"MA Fischbach","year":"2018","unstructured":"Fischbach, M. A. Microbiome: focus on causation and mechanism. Cell 174, 785\u2013790 (2018).","journal-title":"Cell"},{"key":"76412_CR55","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1093\/infdis\/jiaa706","volume":"224","author":"MY Giovanni","year":"2021","unstructured":"Giovanni, M. Y., Schneider, J. S., Calder, T. & Fauci, A. S. Refocusing human microbiota research in infectious and immune-mediated diseases: advancing to the next stage. J. Infect. Dis. 224, 5\u20138 (2021).","journal-title":"J. Infect. Dis."},{"key":"76412_CR56","doi-asserted-by":"crossref","unstructured":"Wu, M. et al. Gut complement induced by the microbiota combats pathogens and spares commensals. Cell 187, 897\u2013913 (2024).","DOI":"10.1016\/j.cell.2023.12.036"},{"key":"76412_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16222-8","volume":"11","author":"I Vujkovic-Cvijin","year":"2020","unstructured":"Vujkovic-Cvijin, I. et al. HIV-associated gut dysbiosis is independent of sexual practice and correlates with noncommunicable diseases. Nat. Commun. 11, 2448 (2020).","journal-title":"Nat. Commun."},{"key":"76412_CR58","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1038\/mi.2013.116","volume":"7","author":"SM Dillon","year":"2014","unstructured":"Dillon, S. M. et al. An altered intestinal mucosal microbiome in HIV-1 infection is associated with mucosal and systemic immune activation and endotoxemia. Mucosal Immunol. 7, 983\u2013994 (2014).","journal-title":"Mucosal Immunol."},{"key":"76412_CR59","doi-asserted-by":"publisher","DOI":"10.1186\/2049-2618-1-26","volume":"1","author":"IH McHardy","year":"2013","unstructured":"McHardy, I. H. et al. HIV Infection is associated with compositional and functional shifts in the rectal mucosal microbiota. Microbiome 1, 26 (2013).","journal-title":"Microbiome"},{"key":"76412_CR60","doi-asserted-by":"publisher","first-page":"e1003829","DOI":"10.1371\/journal.ppat.1003829","volume":"10","author":"EA Mutlu","year":"2014","unstructured":"Mutlu, E. A. et al. A Compositional Look at the Human Gastrointestinal Microbiome and Immune Activation Parameters in HIV Infected Subjects. PLOS Pathog. 10, e1003829 (2014).","journal-title":"PLOS Pathog."},{"key":"76412_CR61","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-87368-8","volume":"11","author":"WB Abange","year":"2021","unstructured":"Abange, W. B. et al. Alteration of the gut fecal microbiome in children living with HIV on antiretroviral therapy in Yaounde, Cameroon. Sci. Rep. 11, 7666 (2021).","journal-title":"Sci. Rep."},{"key":"76412_CR62","doi-asserted-by":"publisher","unstructured":"Guo, C. J. et al. Depletion of microbiome-derived molecules in the host using Clostridium genetics.Science366, https:\/\/doi.org\/10.1126\/science.aav1282 (2019).","DOI":"10.1126\/science.aav1282"},{"key":"76412_CR63","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.cell.2021.12.035","volume":"185","author":"WB Jin","year":"2022","unstructured":"Jin, W. B. et al. Genetic manipulation of gut microbes enables single-gene interrogation in a complex microbiome. Cell 185, 547\u2013562 (2022).","journal-title":"Cell"},{"key":"76412_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112634","volume":"42","author":"D Chatterjee","year":"2023","unstructured":"Chatterjee, D. et al. Identification of aryl hydrocarbon receptor as a barrier to HIV-1 infection and outgrowth in CD4(+) T cells. Cell Rep. 42, 112634 (2023).","journal-title":"Cell Rep."},{"key":"76412_CR65","doi-asserted-by":"publisher","first-page":"e1002427","DOI":"10.1371\/journal.ppat.1002427","volume":"7","author":"T Veiga-Parga","year":"2011","unstructured":"Veiga-Parga, T., Suryawanshi, A. & Rouse, B. T. Controlling viral immuno-inflammatory lesions by modulating aryl hydrocarbon receptor signaling. PLoS Pathog. 7, e1002427 (2011).","journal-title":"PLoS Pathog."},{"key":"76412_CR66","doi-asserted-by":"publisher","unstructured":"Naseri-Nosar, P., Nogalski, M. T. & Shenk, T. The aryl hydrocarbon receptor facilitates the human cytomegalovirus-mediated G1\/S block to cell cycle progression. Proc. Natl. Acad. Sci. USA118, https:\/\/doi.org\/10.1073\/pnas.2026336118 (2021).","DOI":"10.1073\/pnas.2026336118"},{"key":"76412_CR67","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1038\/s41593-020-0664-0","volume":"23","author":"F Giovannoni","year":"2020","unstructured":"Giovannoni, F. et al. AHR is a Zika virus host factor and a candidate target for antiviral therapy. Nat. Neurosci. 23, 939\u2013951 (2020).","journal-title":"Nat. Neurosci."},{"key":"76412_CR68","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/nature06880","volume":"453","author":"FJ Quintana","year":"2008","unstructured":"Quintana, F. J. et al. Control of Treg and TH17 cell differentiation by the aryl hydrocarbon receptor. Nature 453, 65\u201371 (2008).","journal-title":"Nature"},{"key":"76412_CR69","doi-asserted-by":"publisher","unstructured":"Zhou, Y. H. et al. Tryptophan metabolism activates aryl hydrocarbon receptor-mediated pathway to promote HIV-1 infection and reactivation. mBio10, https:\/\/doi.org\/10.1128\/mbio.02591-19 (2019).","DOI":"10.1128\/mbio.02591-19"},{"key":"76412_CR70","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nature06881","volume":"453","author":"M Veldhoen","year":"2008","unstructured":"Veldhoen, M. et al. The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins. Nature 453, 106\u2013109 (2008).","journal-title":"Nature"},{"key":"76412_CR71","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-20197-4","volume":"8","author":"LA Boule","year":"2018","unstructured":"Boule, L. A., Burke, C. G., Jin, G. B. & Lawrence, B. P. Aryl hydrocarbon receptor signaling modulates antiviral immune responses: ligand metabolism rather than chemical source is the stronger predictor of outcome. Sci. Rep. 8, 1826 (2018).","journal-title":"Sci. Rep."},{"key":"76412_CR72","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1007\/s00535-012-0667-z","volume":"48","author":"K Higashitani","year":"2013","unstructured":"Higashitani, K. et al. Association of enhanced activity of indoleamine 2,3-dioxygenase in dendritic cells with the induction of regulatory T cells in chronic hepatitis C infection. J. Gastroenterol. 48, 660\u2013670 (2013).","journal-title":"J. Gastroenterol."},{"key":"76412_CR73","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.humimm.2011.11.002","volume":"73","author":"M Sadeghi","year":"2012","unstructured":"Sadeghi, M. et al. Strong association of phenylalanine and tryptophan metabolites with activated cytomegalovirus infection in kidney transplant recipients. Hum. Immunol. 73, 186\u2013192 (2012).","journal-title":"Hum. Immunol."},{"key":"76412_CR74","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1074\/jbc.RA117.000631","volume":"293","author":"SH Seok","year":"2018","unstructured":"Seok, S. H. et al. Trace derivatives of kynurenine potently activate the aryl hydrocarbon receptor (AHR). J. Biol. Chem. 293, 1994\u20132005 (2018).","journal-title":"J. Biol. Chem."},{"key":"76412_CR75","doi-asserted-by":"publisher","first-page":"3190","DOI":"10.4049\/jimmunol.0903670","volume":"185","author":"JD Mezrich","year":"2010","unstructured":"Mezrich, J. D. et al. An interaction between kynurenine and the aryl hydrocarbon receptor can generate regulatory T cells. J. Immunol. 185, 3190\u20133198 (2010).","journal-title":"J. Immunol."},{"key":"76412_CR76","doi-asserted-by":"publisher","first-page":"19961","DOI":"10.1073\/pnas.1014465107","volume":"107","author":"NT Nguyen","year":"2010","unstructured":"Nguyen, N. T. et al. Aryl hydrocarbon receptor negatively regulates dendritic cell immunogenicity via a kynurenine-dependent mechanism. Proc. Natl. Acad. Sci. USA 107, 19961\u201319966 (2010).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"76412_CR77","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nature10491","volume":"478","author":"CA Opitz","year":"2011","unstructured":"Opitz, C. A. et al. An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor. Nature 478, 197\u2013203 (2011).","journal-title":"Nature"},{"key":"76412_CR78","doi-asserted-by":"publisher","first-page":"4313","DOI":"10.4049\/jimmunol.0803314","volume":"182","author":"A Boasso","year":"2009","unstructured":"Boasso, A. et al. Combined Effect of Antiretroviral Therapy and Blockade of IDO in SIV-Infected Rhesus Macaques1. J. Immunol. 182, 4313\u20134320 (2009).","journal-title":"J. Immunol."},{"key":"76412_CR79","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/1743-422X-10-154","volume":"10","author":"MA O\u2019Connor","year":"2013","unstructured":"O\u2019Connor, M. A. & Green, W. R. The role of indoleamine 2,3-dioxygenase in LP-BPM5 murine retroviral disease progression. Virol. J. 10, 154 (2013).","journal-title":"Virol. J."},{"key":"76412_CR80","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1189\/jlb.1011532","volume":"91","author":"AW Yeung","year":"2012","unstructured":"Yeung, A. W. et al. Flavivirus infection induces indoleamine 2,3-dioxygenase in human monocyte-derived macrophages via tumor necrosis factor and NF-kappaB. J. Leukoc. Biol. 91, 657\u2013666 (2012).","journal-title":"J. Leukoc. Biol."},{"key":"76412_CR81","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.chom.2018.05.003","volume":"23","author":"A Agus","year":"2018","unstructured":"Agus, A., Planchais, J. & Sokol, H. Gut Microbiota Regulation of Tryptophan Metabolism in Health and Disease. Cell Host Microbe 23, 716\u2013724 (2018).","journal-title":"Cell Host Microbe"},{"key":"76412_CR82","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1016\/j.celrep.2015.10.026","volume":"13","author":"I Vujkovic-Cvijin","year":"2015","unstructured":"Vujkovic-Cvijin, I. et al. Gut-resident lactobacillus abundance associates with IDO1 inhibition and Th17 dynamics in SIV-infected macaques. Cell Rep. 13, 1589\u20131597 (2015).","journal-title":"Cell Rep."},{"key":"76412_CR83","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.celrep.2013.03.017","volume":"3","author":"A Cribier","year":"2013","unstructured":"Cribier, A., Descours, B., Valadao, A. L., Laguette, N. & Benkirane, M. Phosphorylation of SAMHD1 by cyclin A2\/CDK1 regulates its restriction activity toward HIV-1. Cell Rep. 3, 1036\u20131043 (2013).","journal-title":"Cell Rep."},{"key":"76412_CR84","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/j.tim.2021.01.014","volume":"29","author":"L Gutierrez-Chamorro","year":"2021","unstructured":"Gutierrez-Chamorro, L., Felip, E., Ezeonwumelu, I. J., Margeli, M. & Ballana, E. Cyclin-dependent Kinases as Emerging Targets for Developing Novel Antiviral Therapeutics. Trends Microbiol. 29, 836\u2013848 (2021).","journal-title":"Trends Microbiol."},{"key":"76412_CR85","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.celrep.2013.03.017","volume":"3","author":"A Cribier","year":"2013","unstructured":"Cribier, A., Descours, B., Valad\u00e3o, A. naL. uizaC., Laguette, N. & Benkirane, M. Phosphorylation of SAMHD1 by cyclin A2\/CDK1 regulates its restriction activity toward HIV-1. Cell Rep. 3, 1036\u20131043 (2013).","journal-title":"Cell Rep."},{"key":"76412_CR86","doi-asserted-by":"publisher","first-page":"5834","DOI":"10.1128\/JVI.00155-14","volume":"88","author":"C St Gelais","year":"2014","unstructured":"St Gelais, C. et al. Identification of cellular proteins interacting with the retroviral restriction factor SAMHD1. J. Virol. 88, 5834\u20135844 (2014).","journal-title":"J. Virol."},{"key":"76412_CR87","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1038\/nm.2964","volume":"18","author":"HM Baldauf","year":"2012","unstructured":"Baldauf, H. M. et al. SAMHD1 restricts HIV-1 infection in resting CD4(+) T cells. Nat. Med. 18, 1682\u20131687 (2012).","journal-title":"Nat. Med."},{"key":"76412_CR88","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/ni.2236","volume":"13","author":"H Lahouassa","year":"2012","unstructured":"Lahouassa, H. et al. SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates. Nat. Immunol. 13, 223\u2013228 (2012).","journal-title":"Nat. Immunol."},{"key":"76412_CR89","doi-asserted-by":"publisher","first-page":"D590","DOI":"10.1093\/nar\/gks1219","volume":"41","author":"C Quast","year":"2013","unstructured":"Quast, C. et al. The SILVA ribosomal RNA gene database project: improved data processing and web-based tools. Nucleic Acids Res. 41, D590\u2013D596 (2013).","journal-title":"Nucleic Acids Res."},{"key":"76412_CR90","doi-asserted-by":"publisher","first-page":"e61217","DOI":"10.1371\/journal.pone.0061217","volume":"8","author":"PJ McMurdie","year":"2013","unstructured":"McMurdie, P. J. & Holmes, S. phyloseq: An R package for reproducible interactive analysis and graphics of microbiome census data. PLOS ONE 8, e61217 (2013).","journal-title":"PLOS ONE"},{"key":"76412_CR91","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"76412_CR92","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1038\/ismej.2012.8","volume":"6","author":"JG Caporaso","year":"2012","unstructured":"Caporaso, J. G. et al. Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms. ISME J. 6, 1621\u20131624 (2012).","journal-title":"ISME J."},{"key":"76412_CR93","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nmeth.3869","volume":"13","author":"BJ Callahan","year":"2016","unstructured":"Callahan, B. J. et al. DADA2: High-resolution sample inference from Illumina amplicon data. Nat. Methods 13, 581\u2013583 (2016).","journal-title":"Nat. Methods"},{"key":"76412_CR94","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1097\/JU.0000000000001940","volume":"206","author":"MH Vaughan","year":"2021","unstructured":"Vaughan, M. H. et al. The urinary microbiome in postmenopausal women with recurrent urinary tract infections. J. Urol. 206, 1222\u20131231 (2021).","journal-title":"J. Urol."},{"key":"76412_CR95","doi-asserted-by":"publisher","unstructured":"Goswami, R. et al. Analytical treatment interruption after short-term antiretroviral therapy in a postnatally simian-human immunodeficiency virus-infected infant rhesus macaque model.mBio10, https:\/\/doi.org\/10.1128\/mbio.01971-19 (2019).","DOI":"10.1128\/mbio.01971-19"},{"key":"76412_CR96","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1126\/science.1167525","volume":"323","author":"W H\u00fcbner","year":"2009","unstructured":"H\u00fcbner, W. et al. Quantitative 3D video microscopy of HIV transfer across T cell virological synapses. Science 323, 1743\u20131747 (2009).","journal-title":"Science"},{"key":"76412_CR97","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1128\/JVI.02853-13","volume":"88","author":"A deCamp","year":"2014","unstructured":"deCamp, A. et al. Global panel of HIV-1 Env reference strains for standardized assessments of vaccine-elicited neutralizing antibodies. J. Virol. 88, 2489\u20132507 (2014).","journal-title":"J. Virol."},{"key":"76412_CR98","doi-asserted-by":"publisher","first-page":"e1006944","DOI":"10.1371\/journal.ppat.1006944","volume":"14","author":"A Kumar","year":"2018","unstructured":"Kumar, A. et al. Infant transmitted\/founder HIV-1 viruses from peripartum transmission are neutralization resistant to paired maternal plasma. PLOS Pathog. 14, e1006944 (2018).","journal-title":"PLOS Pathog."},{"key":"76412_CR99","doi-asserted-by":"publisher","first-page":"14976","DOI":"10.1073\/pnas.2136652100","volume":"100","author":"E Murphy","year":"2003","unstructured":"Murphy, E. et al. Coding potential of laboratory and clinical strains of human cytomegalovirus. Proc. Natl. Acad. Sci. USA 100, 14976\u201314981 (2003).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"76412_CR100","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1128\/MCB.23.6.1885-1895.2003","volume":"23","author":"RF Kalejta","year":"2003","unstructured":"Kalejta, R. F., Bechtel, J. T. & Shenk, T. Human cytomegalovirus pp71 stimulates cell cycle progression by inducing the proteasome-dependent degradation of the retinoblastoma family of tumor suppressors. Mol. Cell Biol. 23, 1885\u20131895 (2003).","journal-title":"Mol. Cell Biol."},{"key":"76412_CR101","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.mimet.2009.05.004","volume":"78","author":"JT Heap","year":"2009","unstructured":"Heap, J. T., Pennington, O. J., Cartman, S. T. & Minton, N. P. A modular system for Clostridium shuttle plasmids. J. Microbiol. Methods 78, 79\u201385 (2009).","journal-title":"J. Microbiol. Methods"},{"key":"76412_CR102","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1002\/(SICI)1097-0231(19990228)13:4<279::AID-RCM478>3.0.CO;2-I","volume":"13","author":"JM Halket","year":"1999","unstructured":"Halket, J. M. et al. Deconvolution gas chromatography\/mass spectrometry of urinary organic acids-potential for pattern recognition and automated identification of metabolic disorders. Rapid Commun. Mass Spectrom. 13, 279\u2013284 (1999).","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"76412_CR103","doi-asserted-by":"publisher","first-page":"10038","DOI":"10.1021\/ac9019522","volume":"81","author":"T Kind","year":"2009","unstructured":"Kind, T. et al. FiehnLib: mass spectral and retention index libraries for metabolomics based on quadrupole and time-of-flight gas chromatography\/mass spectrometry. Anal. Chem. 81, 10038\u201310048 (2009).","journal-title":"Anal. Chem."},{"key":"76412_CR104","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1093\/bioinformatics\/bti236","volume":"21","author":"J Kopka","year":"2005","unstructured":"Kopka, J. et al. GMD@CSB.DB: the Golm Metabolome Database. Bioinformatics 21, 1635\u20131638 (2005).","journal-title":"Bioinformatics"},{"key":"76412_CR105","doi-asserted-by":"publisher","unstructured":"Beghini, F. et al. Integrating taxonomic, functional, and strain-level profiling of diverse microbial communities with bioBakery 3. ELife10, https:\/\/doi.org\/10.7554\/elife.65088 (2021).","DOI":"10.7554\/elife.65088"},{"key":"76412_CR106","unstructured":"The UniProt, C. UniProt: the Universal protein knowledgebase in 2023. Nucleic Acids Res.51, D523\u2013D531 (2023)."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76412-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76412-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76412-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:06:19Z","timestamp":1789085179000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76412-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,13]]},"references-count":106,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["76412"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-76412-8","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,13]]},"assertion":[{"value":"23 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.S.K. serves as a consultant for Merck. S.R.P. serves as a consultant for Moderna, Pfizer, Dynavax, and GSK on their CMV vaccine programs, and has led sponsored research programs with Moderna, Dynavax, and Pfizer on CMV vaccines. D.J., C.Y.T., S.R.P., R.G., and N.K.S. are inventors on a patent application submitted by Duke University that covers the therapeutic use of ArAT-expressing bacteria and their metabolites in viral infections. Other authors have no conflict of interest to disclose.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"9701"}}